ArticleBiotechnology letters2025
Extremophilic microbes tolerate high concentrations of rare earth elements (REEs).
Article in Biotechnology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bacterial diversity in ferruginous duricrust (canga) and the physicochemical variables affecting their prevalence, distribution and predicted metabolic pathways.Antonie van Leeuwenhoek · 2026Article
- The outer membrane inApplied and environmental microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
As demand for rare earth elements (REEs) increases, biotechnological solutions to their extraction and purification are becoming more critical. Identification of chassis organisms capable of surviving in high REE concentrations is a crucial step towards development of sustainable biotechnologies. In this study, we show that growth of mesophilic Escherichia coli is not significantly inhibited by < 300 µM REEs in complex media of, but in phosphate-depleted minimal media a half-maximum inhibitory concentration (IC
Indexed as
Identifiers
40987947What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.